The U.S. Food and Drug Administration (FDA) has approved a drug for treating patients with a rare form of neurological disease called amyotrophic lateral sclerosis (ALS). ALS affects motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle movements like walking, chewing, breathing, and talking. An individual suffering from ALS loses the…
‘Toxic’ Protein Linked to Multiple Forms of Motor Neurone Disease
August 14, 2022
admin
amyotrophic lateral sclerosisAustraliaautoimmune diseaseBrighthealthHealth ConditionshereditaryMotor Neurone DiseasemutationNervous SystemSOD1 proteinWorld
0 Comment
An abnormal protein known to cause rare genetic forms of motor neurone disease (MND) could be implicated in nerve cell death in all forms of the condition, Australian researchers have found. The study, led by researchers from the University of Sydney’s Brain and Mind Centre and published in the neuroscience journal “Brain,” is the first…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta